Page last updated: 2024-09-03

san 58035 and ici 164384

san 58035 has been researched along with ici 164384 in 1 studies

Compound Research Comparison

Studies
(san 58035)
Trials
(san 58035)
Recent Studies (post-2010)
(san 58035)
Studies
(ici 164384)
Trials
(ici 164384)
Recent Studies (post-2010) (ici 164384)
5811223402

Protein Interaction Comparison

ProteinTaxonomysan 58035 (IC50)ici 164384 (IC50)
Estrogen receptorHomo sapiens (human)0.195

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balaguer, P; Boubekeur, N; de Medina, P; Favre, G; Poirot, M; Silvente-Poirot, S1

Other Studies

1 other study(ies) available for san 58035 and ici 164384

ArticleYear
The prototypical inhibitor of cholesterol esterification, Sah 58-035 [3-[decyldimethylsilyl]-n-[2-(4-methylphenyl)-1-phenylethyl]propanamide], is an agonist of estrogen receptors.
    The Journal of pharmacology and experimental therapeutics, 2006, Volume: 319, Issue:1

    Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Estradiol; Humans; Models, Molecular; Organosilicon Compounds; Polyunsaturated Alkamides; Receptors, Estrogen; Sterol O-Acyltransferase; Transcription, Genetic

2006